Page last updated: 2024-09-03

lhrh, gln(8)- and cetrorelix

lhrh, gln(8)- has been researched along with cetrorelix in 1 studies

Compound Research Comparison

Studies
(lhrh, gln(8)-)
Trials
(lhrh, gln(8)-)
Recent Studies (post-2010)
(lhrh, gln(8)-)
Studies
(cetrorelix)
Trials
(cetrorelix)
Recent Studies (post-2010) (cetrorelix)
4302609157157

Protein Interaction Comparison

ProteinTaxonomylhrh, gln(8)- (IC50)cetrorelix (IC50)
Gonadotropin-releasing hormone receptorHomo sapiens (human)0.0042

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bjorklund, CC; Chang, CC; Feng, Y; Liao, B; O'Hare, J; Orlowski, RZ; Schally, AV; Shi, ZZ; Wang, M; Wen, J; Zu, Y1

Other Studies

1 other study(ies) available for lhrh, gln(8)- and cetrorelix

ArticleYear
Luteinizing Hormone-Releasing Hormone (LHRH)-I antagonist cetrorelix inhibits myeloma cell growth in vitro and in vivo.
    Molecular cancer therapeutics, 2011, Volume: 10, Issue:1

    Topics: Animals; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Cell Survival; Down-Regulation; Female; Gonadotropin-Releasing Hormone; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Phosphorylation; Pyrrolidonecarboxylic Acid; Transfection; Xenograft Model Antitumor Assays

2011